世界の整形外科腫瘍治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Orthopedic Oncology Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4631 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、整形外科腫瘍治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（軟部組織切除/切除、患肢救済手術、切断、補助化学療法、再建手術）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・整形外科腫瘍治療の市場動向 ・企業の競争状況、市場シェア ・整形外科腫瘍治療の種類別市場規模と予測2016-2027（軟部組織切除/切除、患肢救済手術、切断、補助化学療法、再建手術） ・整形外科腫瘍治療の用途別市場規模と予測2016-2027（病院、クリニック、その他） ・整形外科腫瘍治療の北米市場規模2016-2027（アメリカ、カナダ） ・整形外科腫瘍治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・整形外科腫瘍治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・整形外科腫瘍治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・整形外科腫瘍治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Stryker Corporation、Zimmer Biomet Holdings, Inc.、Smith & Nephew plc、DePuy Synthes (Johnson & Johnson)、Medtronic、Accentus Medical、Roche Holding AG、Amgen, Inc.、Novartis AG、GlaxoSmithKline、Sanofi、Pfizer Inc.） ・結論

Orthopedic oncology accounts for a very small percentage in the field of orthopedics due to fact that the incidences of bone and soft tissue tumors are rare as compared to the benign tumors of musculoskeletal system which includes trauma, spine, hand and upper extremity, total joints and even pediatric orthopedics.

Market Analysis and Insights: Global Orthopedic Oncology Treatment Market
The global Orthopedic Oncology Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Orthopedic Oncology Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Orthopedic Oncology Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Orthopedic Oncology Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Orthopedic Oncology Treatment market.

Global Orthopedic Oncology Treatment Scope and Market Size
Orthopedic Oncology Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Orthopedic Oncology Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Soft Tissue Excisions/Resections
Limb Salvage Surgery
Amputation
Adjuvant Chemotherapy
Reconstructive Surgery

Segment by Application
Hospitals
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Stryker Corporation
Zimmer Biomet Holdings, Inc.
Smith & Nephew plc
DePuy Synthes (Johnson & Johnson)
Medtronic
Accentus Medical
Roche Holding AG
Amgen, Inc.
Novartis AG
GlaxoSmithKline
Sanofi
Pfizer Inc.

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Orthopedic Oncology Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Soft Tissue Excisions/Resections
1.2.3 Limb Salvage Surgery
1.2.4 Amputation
1.2.5 Adjuvant Chemotherapy
1.2.6 Reconstructive Surgery
1.3 Market by Application
1.3.1 Global Orthopedic Oncology Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Orthopedic Oncology Treatment Market Perspective (2016-2027)
2.2 Orthopedic Oncology Treatment Growth Trends by Regions
2.2.1 Orthopedic Oncology Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Orthopedic Oncology Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Orthopedic Oncology Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Orthopedic Oncology Treatment Industry Dynamic
2.3.1 Orthopedic Oncology Treatment Market Trends
2.3.2 Orthopedic Oncology Treatment Market Drivers
2.3.3 Orthopedic Oncology Treatment Market Challenges
2.3.4 Orthopedic Oncology Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Orthopedic Oncology Treatment Players by Revenue
3.1.1 Global Top Orthopedic Oncology Treatment Players by Revenue (2016-2021)
3.1.2 Global Orthopedic Oncology Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Orthopedic Oncology Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Orthopedic Oncology Treatment Revenue
3.4 Global Orthopedic Oncology Treatment Market Concentration Ratio
3.4.1 Global Orthopedic Oncology Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Orthopedic Oncology Treatment Revenue in 2020
3.5 Orthopedic Oncology Treatment Key Players Head office and Area Served
3.6 Key Players Orthopedic Oncology Treatment Product Solution and Service
3.7 Date of Enter into Orthopedic Oncology Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Orthopedic Oncology Treatment Breakdown Data by Type
4.1 Global Orthopedic Oncology Treatment Historic Market Size by Type (2016-2021)
4.2 Global Orthopedic Oncology Treatment Forecasted Market Size by Type (2022-2027)

5 Orthopedic Oncology Treatment Breakdown Data by Application
5.1 Global Orthopedic Oncology Treatment Historic Market Size by Application (2016-2021)
5.2 Global Orthopedic Oncology Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Orthopedic Oncology Treatment Market Size (2016-2027)
6.2 North America Orthopedic Oncology Treatment Market Size by Type
6.2.1 North America Orthopedic Oncology Treatment Market Size by Type (2016-2021)
6.2.2 North America Orthopedic Oncology Treatment Market Size by Type (2022-2027)
6.2.3 North America Orthopedic Oncology Treatment Market Size by Type (2016-2027)
6.3 North America Orthopedic Oncology Treatment Market Size by Application
6.3.1 North America Orthopedic Oncology Treatment Market Size by Application (2016-2021)
6.3.2 North America Orthopedic Oncology Treatment Market Size by Application (2022-2027)
6.3.3 North America Orthopedic Oncology Treatment Market Size by Application (2016-2027)
6.4 North America Orthopedic Oncology Treatment Market Size by Country
6.4.1 North America Orthopedic Oncology Treatment Market Size by Country (2016-2021)
6.4.2 North America Orthopedic Oncology Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Orthopedic Oncology Treatment Market Size (2016-2027)
7.2 Europe Orthopedic Oncology Treatment Market Size by Type
7.2.1 Europe Orthopedic Oncology Treatment Market Size by Type (2016-2021)
7.2.2 Europe Orthopedic Oncology Treatment Market Size by Type (2022-2027)
7.2.3 Europe Orthopedic Oncology Treatment Market Size by Type (2016-2027)
7.3 Europe Orthopedic Oncology Treatment Market Size by Application
7.3.1 Europe Orthopedic Oncology Treatment Market Size by Application (2016-2021)
7.3.2 Europe Orthopedic Oncology Treatment Market Size by Application (2022-2027)
7.3.3 Europe Orthopedic Oncology Treatment Market Size by Application (2016-2027)
7.4 Europe Orthopedic Oncology Treatment Market Size by Country
7.4.1 Europe Orthopedic Oncology Treatment Market Size by Country (2016-2021)
7.4.2 Europe Orthopedic Oncology Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Orthopedic Oncology Treatment Market Size (2016-2027)
8.2 Asia-Pacific Orthopedic Oncology Treatment Market Size by Type
8.2.1 Asia-Pacific Orthopedic Oncology Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Orthopedic Oncology Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Orthopedic Oncology Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Orthopedic Oncology Treatment Market Size by Application
8.3.1 Asia-Pacific Orthopedic Oncology Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Orthopedic Oncology Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Orthopedic Oncology Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Orthopedic Oncology Treatment Market Size by Region
8.4.1 Asia-Pacific Orthopedic Oncology Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Orthopedic Oncology Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Orthopedic Oncology Treatment Market Size (2016-2027)
9.2 Latin America Orthopedic Oncology Treatment Market Size by Type
9.2.1 Latin America Orthopedic Oncology Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Orthopedic Oncology Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Orthopedic Oncology Treatment Market Size by Type (2016-2027)
9.3 Latin America Orthopedic Oncology Treatment Market Size by Application
9.3.1 Latin America Orthopedic Oncology Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Orthopedic Oncology Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Orthopedic Oncology Treatment Market Size by Application (2016-2027)
9.4 Latin America Orthopedic Oncology Treatment Market Size by Country
9.4.1 Latin America Orthopedic Oncology Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Orthopedic Oncology Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Orthopedic Oncology Treatment Market Size (2016-2027)
10.2 Middle East & Africa Orthopedic Oncology Treatment Market Size by Type
10.2.1 Middle East & Africa Orthopedic Oncology Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Orthopedic Oncology Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Orthopedic Oncology Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Orthopedic Oncology Treatment Market Size by Application
10.3.1 Middle East & Africa Orthopedic Oncology Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Orthopedic Oncology Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Orthopedic Oncology Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Orthopedic Oncology Treatment Market Size by Country
10.4.1 Middle East & Africa Orthopedic Oncology Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Orthopedic Oncology Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Stryker Corporation
11.1.1 Stryker Corporation Company Details
11.1.2 Stryker Corporation Business Overview
11.1.3 Stryker Corporation Orthopedic Oncology Treatment Introduction
11.1.4 Stryker Corporation Revenue in Orthopedic Oncology Treatment Business (2016-2021)
11.1.5 Stryker Corporation Recent Development
11.2 Zimmer Biomet Holdings, Inc.
11.2.1 Zimmer Biomet Holdings, Inc. Company Details
11.2.2 Zimmer Biomet Holdings, Inc. Business Overview
11.2.3 Zimmer Biomet Holdings, Inc. Orthopedic Oncology Treatment Introduction
11.2.4 Zimmer Biomet Holdings, Inc. Revenue in Orthopedic Oncology Treatment Business (2016-2021)
11.2.5 Zimmer Biomet Holdings, Inc. Recent Development
11.3 Smith & Nephew plc
11.3.1 Smith & Nephew plc Company Details
11.3.2 Smith & Nephew plc Business Overview
11.3.3 Smith & Nephew plc Orthopedic Oncology Treatment Introduction
11.3.4 Smith & Nephew plc Revenue in Orthopedic Oncology Treatment Business (2016-2021)
11.3.5 Smith & Nephew plc Recent Development
11.4 DePuy Synthes (Johnson & Johnson)
11.4.1 DePuy Synthes (Johnson & Johnson) Company Details
11.4.2 DePuy Synthes (Johnson & Johnson) Business Overview
11.4.3 DePuy Synthes (Johnson & Johnson) Orthopedic Oncology Treatment Introduction
11.4.4 DePuy Synthes (Johnson & Johnson) Revenue in Orthopedic Oncology Treatment Business (2016-2021)
11.4.5 DePuy Synthes (Johnson & Johnson) Recent Development
11.5 Medtronic
11.5.1 Medtronic Company Details
11.5.2 Medtronic Business Overview
11.5.3 Medtronic Orthopedic Oncology Treatment Introduction
11.5.4 Medtronic Revenue in Orthopedic Oncology Treatment Business (2016-2021)
11.5.5 Medtronic Recent Development
11.6 Accentus Medical
11.6.1 Accentus Medical Company Details
11.6.2 Accentus Medical Business Overview
11.6.3 Accentus Medical Orthopedic Oncology Treatment Introduction
11.6.4 Accentus Medical Revenue in Orthopedic Oncology Treatment Business (2016-2021)
11.6.5 Accentus Medical Recent Development
11.7 Roche Holding AG
11.7.1 Roche Holding AG Company Details
11.7.2 Roche Holding AG Business Overview
11.7.3 Roche Holding AG Orthopedic Oncology Treatment Introduction
11.7.4 Roche Holding AG Revenue in Orthopedic Oncology Treatment Business (2016-2021)
11.7.5 Roche Holding AG Recent Development
11.8 Amgen, Inc.
11.8.1 Amgen, Inc. Company Details
11.8.2 Amgen, Inc. Business Overview
11.8.3 Amgen, Inc. Orthopedic Oncology Treatment Introduction
11.8.4 Amgen, Inc. Revenue in Orthopedic Oncology Treatment Business (2016-2021)
11.8.5 Amgen, Inc. Recent Development
11.9 Novartis AG
11.9.1 Novartis AG Company Details
11.9.2 Novartis AG Business Overview
11.9.3 Novartis AG Orthopedic Oncology Treatment Introduction
11.9.4 Novartis AG Revenue in Orthopedic Oncology Treatment Business (2016-2021)
11.9.5 Novartis AG Recent Development
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Company Details
11.10.2 GlaxoSmithKline Business Overview
11.10.3 GlaxoSmithKline Orthopedic Oncology Treatment Introduction
11.10.4 GlaxoSmithKline Revenue in Orthopedic Oncology Treatment Business (2016-2021)
11.10.5 GlaxoSmithKline Recent Development
11.11 Sanofi
11.11.1 Sanofi Company Details
11.11.2 Sanofi Business Overview
11.11.3 Sanofi Orthopedic Oncology Treatment Introduction
11.11.4 Sanofi Revenue in Orthopedic Oncology Treatment Business (2016-2021)
11.11.5 Sanofi Recent Development
11.12 Pfizer Inc.
11.12.1 Pfizer Inc. Company Details
11.12.2 Pfizer Inc. Business Overview
11.12.3 Pfizer Inc. Orthopedic Oncology Treatment Introduction
11.12.4 Pfizer Inc. Revenue in Orthopedic Oncology Treatment Business (2016-2021)
11.12.5 Pfizer Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Orthopedic Oncology Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Soft Tissue Excisions/Resections
Table 3. Key Players of Limb Salvage Surgery
Table 4. Key Players of Amputation
Table 5. Key Players of Adjuvant Chemotherapy
Table 6. Key Players of Reconstructive Surgery
Table 7. Global Orthopedic Oncology Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Orthopedic Oncology Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Orthopedic Oncology Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Orthopedic Oncology Treatment Market Share by Regions (2016-2021)
Table 11. Global Orthopedic Oncology Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Orthopedic Oncology Treatment Market Share by Regions (2022-2027)
Table 13. Orthopedic Oncology Treatment Market Trends
Table 14. Orthopedic Oncology Treatment Market Drivers
Table 15. Orthopedic Oncology Treatment Market Challenges
Table 16. Orthopedic Oncology Treatment Market Restraints
Table 17. Global Orthopedic Oncology Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Orthopedic Oncology Treatment Market Share by Players (2016-2021)
Table 19. Global Top Orthopedic Oncology Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Orthopedic Oncology Treatment as of 2020)
Table 20. Ranking of Global Top Orthopedic Oncology Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Orthopedic Oncology Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Orthopedic Oncology Treatment Product Solution and Service
Table 24. Date of Enter into Orthopedic Oncology Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Orthopedic Oncology Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Orthopedic Oncology Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Orthopedic Oncology Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Orthopedic Oncology Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Orthopedic Oncology Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Orthopedic Oncology Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Orthopedic Oncology Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Orthopedic Oncology Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Orthopedic Oncology Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Orthopedic Oncology Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Orthopedic Oncology Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Orthopedic Oncology Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Orthopedic Oncology Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Orthopedic Oncology Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Orthopedic Oncology Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Orthopedic Oncology Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Orthopedic Oncology Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Orthopedic Oncology Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Orthopedic Oncology Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Orthopedic Oncology Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Orthopedic Oncology Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Orthopedic Oncology Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Orthopedic Oncology Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Orthopedic Oncology Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Orthopedic Oncology Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Orthopedic Oncology Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Orthopedic Oncology Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Orthopedic Oncology Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Orthopedic Oncology Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Orthopedic Oncology Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Orthopedic Oncology Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Orthopedic Oncology Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Orthopedic Oncology Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Orthopedic Oncology Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Orthopedic Oncology Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Orthopedic Oncology Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Orthopedic Oncology Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Orthopedic Oncology Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. Stryker Corporation Company Details
Table 65. Stryker Corporation Business Overview
Table 66. Stryker Corporation Orthopedic Oncology Treatment Product
Table 67. Stryker Corporation Revenue in Orthopedic Oncology Treatment Business (2016-2021) & (US$ Million)
Table 68. Stryker Corporation Recent Development
Table 69. Zimmer Biomet Holdings, Inc. Company Details
Table 70. Zimmer Biomet Holdings, Inc. Business Overview
Table 71. Zimmer Biomet Holdings, Inc. Orthopedic Oncology Treatment Product
Table 72. Zimmer Biomet Holdings, Inc. Revenue in Orthopedic Oncology Treatment Business (2016-2021) & (US$ Million)
Table 73. Zimmer Biomet Holdings, Inc. Recent Development
Table 74. Smith & Nephew plc Company Details
Table 75. Smith & Nephew plc Business Overview
Table 76. Smith & Nephew plc Orthopedic Oncology Treatment Product
Table 77. Smith & Nephew plc Revenue in Orthopedic Oncology Treatment Business (2016-2021) & (US$ Million)
Table 78. Smith & Nephew plc Recent Development
Table 79. DePuy Synthes (Johnson & Johnson) Company Details
Table 80. DePuy Synthes (Johnson & Johnson) Business Overview
Table 81. DePuy Synthes (Johnson & Johnson) Orthopedic Oncology Treatment Product
Table 82. DePuy Synthes (Johnson & Johnson) Revenue in Orthopedic Oncology Treatment Business (2016-2021) & (US$ Million)
Table 83. DePuy Synthes (Johnson & Johnson) Recent Development
Table 84. Medtronic Company Details
Table 85. Medtronic Business Overview
Table 86. Medtronic Orthopedic Oncology Treatment Product
Table 87. Medtronic Revenue in Orthopedic Oncology Treatment Business (2016-2021) & (US$ Million)
Table 88. Medtronic Recent Development
Table 89. Accentus Medical Company Details
Table 90. Accentus Medical Business Overview
Table 91. Accentus Medical Orthopedic Oncology Treatment Product
Table 92. Accentus Medical Revenue in Orthopedic Oncology Treatment Business (2016-2021) & (US$ Million)
Table 93. Accentus Medical Recent Development
Table 94. Roche Holding AG Company Details
Table 95. Roche Holding AG Business Overview
Table 96. Roche Holding AG Orthopedic Oncology Treatment Product
Table 97. Roche Holding AG Revenue in Orthopedic Oncology Treatment Business (2016-2021) & (US$ Million)
Table 98. Roche Holding AG Recent Development
Table 99. Amgen, Inc. Company Details
Table 100. Amgen, Inc. Business Overview
Table 101. Amgen, Inc. Revenue in Orthopedic Oncology Treatment Business (2016-2021) & (US$ Million)
Table 102. Amgen, Inc. Recent Development
Table 103. Novartis AG Company Details
Table 104. Novartis AG Business Overview
Table 105. Novartis AG Orthopedic Oncology Treatment Product
Table 106. Novartis AG Revenue in Orthopedic Oncology Treatment Business (2016-2021) & (US$ Million)
Table 107. Novartis AG Recent Development
Table 108. GlaxoSmithKline Company Details
Table 109. GlaxoSmithKline Business Overview
Table 110. GlaxoSmithKline Orthopedic Oncology Treatment Product
Table 111. GlaxoSmithKline Revenue in Orthopedic Oncology Treatment Business (2016-2021) & (US$ Million)
Table 112. GlaxoSmithKline Recent Development
Table 113. Sanofi Company Details
Table 114. Sanofi Business Overview
Table 115. Sanofi Orthopedic Oncology Treatment Product
Table 116. Sanofi Revenue in Orthopedic Oncology Treatment Business (2016-2021) & (US$ Million)
Table 117. Sanofi Recent Development
Table 118. Pfizer Inc. Company Details
Table 119. Pfizer Inc. Business Overview
Table 120. Pfizer Inc. Orthopedic Oncology Treatment Product
Table 121. Pfizer Inc. Revenue in Orthopedic Oncology Treatment Business (2016-2021) & (US$ Million)
Table 122. Pfizer Inc. Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Orthopedic Oncology Treatment Market Share by Type: 2020 VS 2027
Figure 2. Soft Tissue Excisions/Resections Features
Figure 3. Limb Salvage Surgery Features
Figure 4. Amputation Features
Figure 5. Adjuvant Chemotherapy Features
Figure 6. Reconstructive Surgery Features
Figure 7. Global Orthopedic Oncology Treatment Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Orthopedic Oncology Treatment Report Years Considered
Figure 12. Global Orthopedic Oncology Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Orthopedic Oncology Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Orthopedic Oncology Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Orthopedic Oncology Treatment Market Share by Regions (2022-2027)
Figure 16. Global Orthopedic Oncology Treatment Market Share by Players in 2020
Figure 17. Global Top Orthopedic Oncology Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Orthopedic Oncology Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Orthopedic Oncology Treatment Revenue in 2020
Figure 19. Global Orthopedic Oncology Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Orthopedic Oncology Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Orthopedic Oncology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Orthopedic Oncology Treatment Market Share by Type (2016-2027)
Figure 23. North America Orthopedic Oncology Treatment Market Share by Application (2016-2027)
Figure 24. North America Orthopedic Oncology Treatment Market Share by Country (2016-2027)
Figure 25. United States Orthopedic Oncology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Orthopedic Oncology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Orthopedic Oncology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Orthopedic Oncology Treatment Market Share by Type (2016-2027)
Figure 29. Europe Orthopedic Oncology Treatment Market Share by Application (2016-2027)
Figure 30. Europe Orthopedic Oncology Treatment Market Share by Country (2016-2027)
Figure 31. Germany Orthopedic Oncology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Orthopedic Oncology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Orthopedic Oncology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Orthopedic Oncology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Orthopedic Oncology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Orthopedic Oncology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Orthopedic Oncology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Orthopedic Oncology Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Orthopedic Oncology Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Orthopedic Oncology Treatment Market Share by Region (2016-2027)
Figure 41. China Orthopedic Oncology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Orthopedic Oncology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Orthopedic Oncology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Orthopedic Oncology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Orthopedic Oncology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Orthopedic Oncology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Orthopedic Oncology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Orthopedic Oncology Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Orthopedic Oncology Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Orthopedic Oncology Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Orthopedic Oncology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Orthopedic Oncology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Orthopedic Oncology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Orthopedic Oncology Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Orthopedic Oncology Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Orthopedic Oncology Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Orthopedic Oncology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Orthopedic Oncology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Orthopedic Oncology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Stryker Corporation Revenue Growth Rate in Orthopedic Oncology Treatment Business (2016-2021)
Figure 61. Zimmer Biomet Holdings, Inc. Revenue Growth Rate in Orthopedic Oncology Treatment Business (2016-2021)
Figure 62. Smith & Nephew plc Revenue Growth Rate in Orthopedic Oncology Treatment Business (2016-2021)
Figure 63. DePuy Synthes (Johnson & Johnson) Revenue Growth Rate in Orthopedic Oncology Treatment Business (2016-2021)
Figure 64. Medtronic Revenue Growth Rate in Orthopedic Oncology Treatment Business (2016-2021)
Figure 65. Accentus Medical Revenue Growth Rate in Orthopedic Oncology Treatment Business (2016-2021)
Figure 66. Roche Holding AG Revenue Growth Rate in Orthopedic Oncology Treatment Business (2016-2021)
Figure 67. Amgen, Inc. Revenue Growth Rate in Orthopedic Oncology Treatment Business (2016-2021)
Figure 68. Novartis AG Revenue Growth Rate in Orthopedic Oncology Treatment Business (2016-2021)
Figure 69. GlaxoSmithKline Revenue Growth Rate in Orthopedic Oncology Treatment Business (2016-2021)
Figure 70. Sanofi Revenue Growth Rate in Orthopedic Oncology Treatment Business (2016-2021)
Figure 71. Pfizer Inc. Revenue Growth Rate in Orthopedic Oncology Treatment Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

---